Bookmark and Share

Big Mover; Entest BioMedical Inc. (ENTB)

Shares of Entest BioMedical Inc. (PINK: ENTB), a company engaged in the development of stem cell therapy treatments for chronic obstructive pulmonary disease, are soaring in trading today.

At last check, ENTB shares were trading 48.81% higher at $0.0125 on above average volume of 22.03 million. The stock has now gained more than 160% in the last three trading sessions.

According to a filing made by ENTB earlier this month, the company entered into an Equity Purchase Agreement with Southridge Partners II LP.

As per the terms of the agreement, Southridge will purchase at ENTB’s election up to $10 million of ENTB’s registered common stock.


Leave a Reply




You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

All stories in are for informational purposes only. This is NOT a stock recommendation. This story is a daily light analysis featuring a stock with insider buying. With some caveats, insiders purchase a stock because they think the stock is going up. There are other factors to consider such as size of the transaction relative to their compensation and net worth. Sometimes, insiders might be propping a stock price up for future financing. Sometimes, the amount of insider buying are misread or misreported. Each month, DailyStocks releases a a summary of the stocks with insider buying. Sign up for the free monthly newsletter at . About is the place where you can find stories about stocks with insider buying, where you can educate yourself about stock market investing, and where you can perform the stock search engine analysis – you enter a stock symbol, and you get a resulting page of stock ticker indexed links so that you do not have to type the stock symbol each time.